Conversion
Up Press Release Schematic FAQ

 

Press Release

Schematic

FAQ

Hereditary Colorectal Cancer Registry

 

Disclosure

Under a licensing agreement between The Johns Hopkins University and GMP Companies, Inc. (Ft. Lauderdale, FL), the Conversion technology is exclusively licensed to GMP for worldwide commercial applications. Bert Vogelstein, M.D., Kenneth W. Kinzler, Ph.D., Hai Yan, Ph.D., and Nicholas Papadopoulos, Ph.D., are entitled to a share of the royalty received by the University from sales of the licensed technology. The Conversion technology will be made freely available to academia for research purposes.  The University and the researchers own GMP Companies, Inc. stock, which is subject to certain restrictions under University policy. The terms of this arrangement are being managed by the University in accordance with its conflict of interest policies.

Home Search Contents